Publications

5891 Results

SWOG S0500 - a randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

Authors
J Smerage;W Barlow;D Hayes;E Winer;B Leyland-Jones;G Srkalovic;S Tejwani;A Schott;MA O'Rourke;D Lew;J Gralow;RB Livingston;GN Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium, abst. S5-07; oral presentation;
Year
2013
Research Committee(s)
Breast
Study Number(s)
S0500

Prognostic value of tumor-infiltrating lympocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Authors
S Adams;R Gray;S Demaria;LJ Goldstein;EA Perez;LN Shulman;S Martino;NE Davidson;G Sledge;J Sparano;S Bavde
Journal / Conference
San Antonio Breast Cancer Symposium, abst S1-07; oral presentation;
Year
2013
Research Committee(s)
Breast
Study Number(s)
E1199, E2197

Prospective evaluation of the utility of the international prognostic score (IPS) for patients with advanced hodgkin lymphoma (HL) treated with contemporary therapy: results from US intergroup trial E2496

Authors
CS Diefenbach;L Hong;LI Gordon;RI Fisher;NL Bartlett;JM Connors;RD Gascoyne;H Wagner;P Stiff;B Cheson;M Gospodarowicz;BS Kahl;JW Friedberg;KH Blum;TM Habermann;JM Tuscano;RT Hoppe;SJ Horning;R Advani
Journal / Conference
Haematologica 98(supplement 2):P010;CS, p.4; International Symposium on Hodgkin Lymphoma (Oct.12-15, 2013, Cologne, Germany), poster presenttion;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E2496

Strategies to overcome barriers to accrual (BtA) to NCI-sponsored clinical trials: a project ofthe NCI-Myeloma Steering Committee Accrual Working Group (NCI-MYSC AWG)

Authors
M Weiss;MA Gertz;RF Little;V Rajkumar;S Jacobus;R Abonour;KC Anderson;B Barlogie;NS Callander;EJ Gorak;J Matous;GM Mills;RC Kane;MS Katz;LA Jensen;J Omel;RZ Orlowski;PGG Richardson;NC Munshi
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 8592); ASCO Annual Meeting
Year
2013
Research Committee(s)
Myeloma

The relationship between quantitative HER2 gene expression by the 21-gene RT-PCR assay and adjuvant trastuzumab (H) benefit in NCCTG (Alliance) N9831

Authors
EA Perez;SM Butler;AC Dueck;F Baehner;F Jamshidian;DB Cherbavaz;EA Thompson;S Shak;PA Kaufman;NE Davidson;J Gralow;Y Asmann;KV Ballman
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 520)
Year
2013
Research Committee(s)
Breast
Study Number(s)
N9831

Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): an Alliance-led analysis

Authors
N Foster;LA Renfro;SE Schild;M Redman;XF Wang;SE Dahlberg;K Ding;PA Bradbury;SS Ramalingam;DR Gandara;E Vokes;AA Adjei;SJ Mandrekar
Journal / Conference
Journal of Clinical Oncology 31(suppl;abstr 7510)
Year
2013
Research Committee(s)
Lung

Clinical, epidemiologic and genomic studies of helicobacter pylori: the role of contaminated water

Authors
M Valdivieso;C Xi;AJ Bussallleu;I Novoa;R Sexton;KF Boehnke;JJ Crowley;GE Goodman;LH Baker
Journal / Conference
International Cancer Control Congress (Nov. 3-6, 2013, Lima, Peru), oral;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S1119

Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association Symptom Score

Authors
D Ankerst;C Till;A Boeck;P Goodman;C Tangen;I Thompson
Journal / Conference
Urology Nov;82(5):1076-81
Year
2013
Research Committee(s)
Cancer Control
PMID
PMID24055241
PMC
PMC3874369
Study Number(s)
SWOG-9217

Evaluation of which patients get a second course of 3+7 on cooperative group trials for newly diagnosed acute myeloid leukemia: a report from SWOG

Authors
M Othus;F Appelbaum;S Petersdorf;HP Erba;E Estey
Journal / Conference
Blood 122:3925; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106

Prediction of CR on reinduction in patients with newly diagnosed acute myeloid leukemia given intensive induction regimens: a report from SWOG and Cleveland Clinic

Authors
M Othus;S Mukherjee;MA Sekeres;J Godwin;J Anderson;S Petersdorf;F Appelbaum;HP Erba;E Estey
Journal / Conference
Blood 122:2686; American Society of Hematology meeting (Dec 7-10, 2013, New Orleans, LA), poster presentation;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333